Some companies are spending billions on AI, but many are spending it backward. Striking data has emerged from Deloitte: 93% of global AI budgets are being poured into technology—models, chips, ...

Slashes FY26 earnings view sharply below consensus Flags soft trading conditions in developed markets Warns of impact from strong Australian dollar Shares end 40.7% lower in worst session ever April ...

SYDNEY--Cochlear shares are on course for their worst day since the hearing-implant maker went public in 1995, tumbling 40% after the Australian company slashed its annual profit guidance on weak U.S.

Delivering chemotherapies is often a race against the clock. Because these are radioactive materials, they deteriorate, requiring tight coordination to get them from manufacturing sites to hospitals ...

Angiotensin-(1–7) lowers blood pressure and improves metabolic outcomes in animal models of obesity and hypertension. Whether central mechanisms are involved in these protective cardiometabolic ...

SYDNEY--Cochlear expects an annual profit at the lower end of its guidance range after negotiations over pricing slowed the rollout of its latest hearing system, contributing to a 21% drop in ...

FRIDAY, Dec. 12, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved an expanded indication for MED-EL (Medical Electronics) cochlear implants for children ages 7 months and ...

The U.S. Food and Drug Administration has approved an expanded indication for MED-EL (Medical Electronics) cochlear implants for children ages 7 months and older with bilateral sensorineural hearing ...

(CNN) — Ben Summers lights up with a smile the moment he talks about the “Batman” theme song or the afternoons he spends playing the piano at his grandmother’s house. Just a few years ago, Ben could ...